Skip to content
healthcare.dev

Olopatadine Hydrochloride

NDC 0536-1445, Olopatadine Hydrochloride Ophthalmic Solution, solution/ drops, from RUGBY LABORATORIES.

Product NDC
0536-1445
Status
Listed
Labeler
RUGBY LABORATORIES
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA206046
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1445 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE1 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
0536-1445-40005361445401 BOTTLE in 1 CARTON (0536-1445-40) / 5 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00536144540

    GET /v1/drugs/nadac/00536144540

Use it

Look up 0536-1445 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1445 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0536-1445. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.